Crossmark

Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024

Crossref DOI link: https://doi.org/10.1016/j.rgmxen.2024.10.009

Published Print: 2025-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Remes-Troche, J.M.

Coss-Adame, E.

Schmulson, M.

García-Zermeño, K.R.

Amieva-Balmori, M.

Carmona-Sánchez, R.

Gómez-Escudero, O.

Gómez-Castaños, P.C.

Icaza-Chávez, M.E.

López-Colombo, A.

Morel-Cerda, E.C.

Valdovinos-Díaz, M.Á.

Valdovinos-García, L.R.

Villar-Chávez, A.S.
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2025-04-10
More Information

This article is maintained by: Elsevier

Article Title: Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024

Journal Title: Revista de Gastroenterología de México (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rgmxen.2024.10.009

Content Type: simple-article

Copyright: © 2025 Published by Masson Doyma México S.A. on behalf of Asociación Mexicana de Gastroenterología.